Above‑Knee Amputation for Chronic Soft‑Tissue and Periprosthetic Joint Infection with Exposed Hardware

by Health Editor — Dr. Nadia Rowe

Clinical scenario

A 73‑year‑old man with a distal femur megaprosthesis presented three months after a revision total knee arthroplasty with a draining sinus, exposed metalwork and progressively worsening pain. Imaging showed periprosthetic joint infection (PJI) involving methicillin‑resistant Staphylococcus aureus and a chronic soft‑tissue ulcer that failed multiple debridements and flap attempts. After multidisciplinary review, the team proceeded with an above‑knee amputation (AKA) to eradicate the infection and protect the remaining limb.

Epidemiology of periprosthetic joint infection

PJI remains one of the most serious complications of joint replacement. According to the CDC, surgical site infections affect roughly 2 % of orthopedic procedures, and the infection rate for primary knee and hip arthroplasty is about 1 % in the United States. The risk climbs to 3 % after aseptic revision surgery and exceeds 20 % when a revision is performed for an existing infection (CDC). The incidence has risen in recent years, driven in part by an aging population, increasing numbers of complex oncologic reconstructions, and greater use of modular megaprostheses.

Challenges of chronic soft‑tissue infection with exposed hardware

When an implant is exposed through ulcerated skin, the risk of biofilm formation intensifies. Biofilms protect bacteria from antibiotics and the host immune response, making eradication without hardware removal extremely difficult (IDSA guideline). Chronic ulceration also predisposes patients to secondary infection with skin flora such as S. epidermidis, as seen in the case report. Repeated debridements, negative‑pressure wound therapy, and local flap coverage are standard measures, yet success rates decline sharply after multiple failures. A systematic review of knee megaprostheses found that chronic soft‑tissue complications were the leading cause of re‑operation, and amputation was required in 12‑18 % of those cases (J Bone Joint Surg).

Surgical decision‑making and guideline recommendations

The Infectious Diseases Society of America (IDSA) recommends a staged approach for chronic PJI: thorough debridement, removal of all hardware, targeted antibiotic therapy, and delayed re‑implantation when feasible. When the soft‑tissue envelope cannot be restored, or when the patient’s physiological reserve is limited, the guideline acknowledges amputation as a limb‑salvage option (IDSA 2013). In the reported case, the patient’s extensive ulceration, persistent drainage, and inability to achieve adequate coverage tipped the balance toward an AKA.

Outcomes after above‑knee amputation

Above‑knee amputation carries significant morbidity. A 2020 cohort study of Medicare beneficiaries reported a 30‑day mortality of 7 % and a one‑year mortality of 20 % following AKA, with higher rates in patients older than 80 years or those with diabetes (JAMA Surgery). Functional outcomes are also limited; only about one‑third of patients achieve independent ambulation with a prosthesis, and many rely on a wheelchair. Psychologically, up to 80 % of amputees experience phantom‑limb pain, and the prevalence of depression and post‑traumatic stress disorder is markedly elevated (NIH). These sequelae underscore the need for integrated rehabilitation, including physical therapy, mental‑health support, and prosthetic training.

Public‑health perspective

The case highlights a convergence of two costly health challenges: PJI and major limb loss. In the United States, PJI‑related hospital expenditures are projected to exceed $1.8 billion annually by 2030 (Reuters Health). When infection forces amputation, the downstream costs of long‑term rehabilitation, prosthetic devices and mental‑health care further strain health systems. Early identification of risk factors—such as obesity, uncontrolled diabetes, or colonization with methicillin‑resistant S. aureus—and aggressive prophylactic measures (e.g., pre‑operative decolonization) can reduce infection rates, according to WHO recommendations on antimicrobial resistance (WHO). Multidisciplinary teams that include orthopaedic surgeons, infectious‑disease specialists, plastic surgeons and rehabilitation experts improve decision‑making and can lower the odds of resorting to amputation.

Implications for patients and clinicians

For patients facing complex joint infections, the possibility of amputation is a stark reality that carries profound physical and emotional consequences. Clinicians must convey the risks, benefits and realistic functional expectations of each surgical option, while ensuring that antibiotic regimens follow evidence‑based protocols. Prompt referral to specialized centers with expertise in megaprosthetic reconstruction and infection management can expand limb‑salvage options and potentially avoid the need for an AKA.

Understanding the interplay between chronic soft‑tissue infection, exposed hardware and periprosthetic joint infection is essential for surgeons, primary‑care providers and policymakers alike. The case reinforces the importance of comprehensive infection control, early multidisciplinary assessment and transparent patient counseling to mitigate the personal and societal burden of these devastating outcomes.

Read more on Globally Pulse Health.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.